Cyclin T1 Expression Is Mediated by a Complex and Constitutively Active Promoter and Does Not Limit Human Immunodeficiency Virus Type 1 Tat Function in Unstimulated Primary Lymphocytes

JOURNAL OFVIROLOGY,

0022-538X/02/$04.00⫹0 DOI: 10.1128/JVI.76.1.208–219.2002Jan. 2002, p. 208–219 Vol. 76, No. 1 Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Cyclin T1 Expression Is Mediated by a Complex and Constitutively

Active Promoter and Does Not Limit Human Immunodeficiency Virus

Type 1 Tat Function in Unstimulated Primary Lymphocytes

Juan Martin-Serrano, Kelvin Li,† and Paul D. Bieniasz*

Aaron Diamond AIDS Research Center, Rockefeller University, New York, New York 10016

Received 9 May 2001/Accepted 25 September 2001

Cyclin T1 (CycT1), a component of positive-transcription-elongation factor-b (P-TEFb), is an essential cofactor for transcriptional activation by lentivirus Tat proteins. It is thought that low CycT1 expression levels restrict human immunodeficiency virus type 1 (HIV-1) expression levels and replication in resting CD4ⴙ

lymphocytes. In this study, we undertook a functional analysis of thecycT1promoter to determine which, if any, promoter elements might be responsible for cellular activation state-dependent CycT1 expression. ThecycT1

gene contains a complex promoter that exhibits an extreme degree of functional redundancy: five nonoverlap-ping fragments were found to exhibit significant promoter activity in immortalized cell lines, and these elements could interact in a synergistic or redundant manner to mediatecycT1transcription. Reporter gene expression, mediated by thecycT1promoter, was detectable in unstimulated transfected primary lymphocytes and multiple sites within the promoter could serve to initiate transcription. While utilization of these start sites was significantly altered by the application of exogenous stimuli to primary lymphocytes and two distinct promoter elements exhibited enhanced activity in the presence of phorbol ester, overallcycT1transcription was only modestly enhanced in response to cell activation. These observations prompted a reexamination of CycT1 protein expression in primary lymphocytes. In fact, steady-state CycT1 expression is only slightly lower in unstimulated lymphocytes compared to phorbol ester-treated cells or a panel of immortalized cell lines. Importantly, CycT1 is expressed at sufficient levels in unstimulated primary cells to support robust Tat activity. These results strongly suggest that CycT1 expression levels in unstimulated primary lymphocytes do not profoundly limit HIV-1 gene expression or provide an adequate mechanistic explanation for proviral latency in vivo.

The human immunodeficiency viruses (HIVs) and related lentiviruses from simian, equine, and bovine species each en-code a transcriptional transactivator (Tat) that dramatically activates transcription by recruiting a form of positive tran-scription elongation factor-b (P-TEFb) to the viral promoter (2, 8–11, 21, 22, 28, 52). P-TEFb is largely responsible for the hyperphosphorylation of the C-terminal domain (CTD) of the RNA polymerase II (RNAPII) large subunit (38, 44), an event associated with the transition of the transcription complex to a processive form (15, 38). Indeed, P-TEFb-induced CTD phos-phorylation overcomes the inhibitory effects on transcription elongation mediated by negative elongation factors (NELF) and DSIF (DRB sensitivity inducing factor) (50, 51, 55). The minimal form of P-TEFb includes either cyclin T1 (CycT1), cyclin T2A (CycT2A), cyclin T2B (CycT2B), or cyclin K, which are regulatory subunits of distinct forms of the P-TEFb com-plex (20, 43). While each of these cyclins can form a comcom-plex with, and thereby activate, the catalytic P-TEFb subunit, CDK9, the majority of CDK9 present in HeLa nuclear extracts is associated with the CycT1 containing form of P-TEFb (43). The lentiviral Tat proteins represent a unique family of transcriptional activators in that they function via

promoter-proximal RNA target sequences, termed TAR elements (17), and activate transcription predominantly at the level of elon-gation (16, 31, 33, 37). Moreover, CycT1, but not CycT2A or CycT2B has been shown to be a functional partner for the lentiviral Tat proteins (7, 41, 53). In fact, Tat proteins bind directly to CycT1 and the resulting Tat–P-TEFb complex sub-sequently binds to the viral TAR element (10, 52, 53). The Tat/TAR axis thus serves to actively recruit P-TEFb to the vicinity of recently initiated RNAPII transcription complexes. With the exception of bovine immunodeficiency virus Tat, which can bind with high affinity to a cognate TAR element in the absence of cellular cofactors (5, 11), CycT1, and possibly CDK9, contribute to the RNA binding affinity and specificity of the Tat–P-TEFb complex (2, 8–10, 19, 22–24, 52, 53). The observation that Tat-mediated transcriptional activation can be recapitulated simply by tethering CycT1 or CDK9 to a promoter-proximal RNA or DNA target argues that P-TEFb recruitment is the sole mechanism by which Tat proteins acti-vate lentiviral gene expression (10, 21, 36).

HIV-1 fails to replicate in unstimulated CD4⫹_lymphocytes.

While blocks at reverse transcription and integration have been shown to contribute to this phenomenon (12, 47, 56), it is also apparent that HIV-1 gene expression is significantly at-tenuated in resting cells. Indeed, significant numbers of inte-grated, but transcriptionally latent, proviruses exist in the rest-ing peripheral blood CD4⫹ _{T-cell population in infected}

individuals. This “latent pool” is a significant obstacle to the eradication of HIV-1 from infected individuals by chemother-* Corresponding author. Mailing address: Aaron Diamond AIDS

Research Center, 455 First Ave., New York, NY 10016. Phone: (212) 448-5070. Fax: (212) 448-5159. E-mail: [email protected].

† Present address: State University of New York, Stony Brook, NY 11794.

208

on November 8, 2019 by guest

http://jvi.asm.org/

apy (14, 18). The mechanisms that govern whether a provirus is latent or transcriptionally active remain only partly under-stood, but it is clear that HIV-1 expression is modulated by the cellular activation state (1, 3, 13, 14, 29, 32, 35, 39). Relevant cellular factors that are functionally upregulated upon T-cell activation include NF-␬B, NFAT, and CycT1. In the latter case, previous work has indicated that CycT1 is expressed at only low levels in unstimulated primary lymphocytes but is responsive to stimulation by phorbol ester- or lectin-mediated cellular activation (25, 26). Therefore, it has been suggested that a relative lack of CycT1 expression might contribute to the failure of HIV-1 to replicate in unstimulated primary lympho-cytes and, in part, explain the lack of proviral transcription in latently infected cells in vivo (25, 26, 44, 48). Because the CycT1 promoter is constitutively active and not significantly responsive to exogenous stimuli in immortalized cell lines (34), it is unclear whether activation induced CycT1 expression in primary lymphocytes is due to transcriptional or posttranscrip-tional mechanisms.

In this study, we performed a functional analysis of thecycT1

promoter to investigate how CycT1 expression is regulated at the transcriptional level in immortalized cell lines and in re-sponse to stimuli in primary lymphocytes. This analysis reveals that thecycT1promoter contains multiple elements that con-tribute to constitutive activity, both in a variety of cell lines and in primary cells. Importantly, although thecycT1promoter is modestly upregulated and exhibits changes in the utilization of transcription initiation sites in response to exogenous stimuli in primary lymphocytes, the basal level of CycT1 expression in unstimulated cells is sufficient to support robust Tat activity. Taken together, these observations suggest that limited Tat function, resulting from only low levels of CycT1 expression, does not provide an adequate mechanistic explanation for the establishment and maintenance of latent proviruses in vivo.

MATERIALS AND METHODS

Cloning and analysis of thecycT1promoter.Genomic DNA sequences cor-responding to the 5⬘region of thecycT1coding sequence were cloned by using the GenomeWalker Kit (Clontech). The first PCR was performed with the AP1 primer (Clontech) and thecycT1specific oligonucleotide T1GP1 (5⬘-TTTGTT GTTGTTCTTCCTCTCTCCCTC-3⬘). This product was used as the template for a nested amplification with the AP2 and T1GP2 (5⬘-CTCCATAGTGCTTCAA CCAGAAGGCAG-3⬘) primers. Two fragments of 2,215 and 2,375 nucleotides were obtained and inserted into pBluescript SK (Stratagene), and four indepen-dent clones were sequenced. The iindepen-dentification of putative transcription factor binding sites was done by using the programs MacVector 6.5.1 (Oxford Molec-ular) and TESS (Transcription Element Search Software [http://www.cbil.upenn .edu/tess/index.html]). Only sequences that were identical to the consensus se-quence for transcription factors in either database were considered. The mouse

cycT1promoter was identified by searching the High Throughput Genomic Sequences database by using the BLAST program (http://www.ncbi.nlm.nih.gov /BLAST/).

Plasmid construction.AnNcoI restriction site underlying the translation ini-tiation codon of cyclin T1 gene (hereafter referred to as position⫹1) was used to insert the 2,051-nucleotide genomic fragment in theSmaI andNcoI sites of the pGL3-basic vector (Promega). Progressive 5⬘-to-3⬘deletions of the genomic sequence were generated by PCR with the appropriate oligonucleotides. The 3⬘-to-5⬘series of deletion mutants were similarly generated by PCR and inserted into thePstI restriction site located at position⫺31 of the CycT1 promoter. The pcTat and pBC12/CMV/lacZ plasmids have been previously described (9, 49) and pHIV/luc was constructed by inserting anXhoI -HindIII fragment compris-ing the 3⬘long terminal repeat (LTR) from pIIIB into theXhoI andHindIII sites of pGL3-basic.

Primer extension analysis.Total RNA was purified from immortalized cell lines and primary lymphocytes using TRIzol reagent (Life Technologies). T-cell

(Jurkat and MT4) monocytic (THP1 and U937), epithelial (HeLa and 293T), and fibroblast (HOS) cell lines were included in these experiments. The T1GP1 oligonucleotide was labeled by using T4 polynucleotide kinase (Life Technolo-gies), and 2⫻105_{cpm were hybridized with 10␮g of RNA at 72°C for 10 min.} The reverse transcription reaction was done at 42°C for 1 h with SuperScript RNase H⫺_{Reverse Transcriptase (Life Technologies). The transcribed products}

were phenol-chloroform extracted, ethanol precipitated, and separated by elec-trophoresis on denaturing 6% acrylamide gels with32_{P-labeledMspI-digested} pBR322 as a size marker.

RNase protection assays.A 206-nucleotide fragment of cycT1cDNA was amplified by PCR and inserted into theHindIII andXhoI sites of pBluescript SK. This plasmid was linearized withHindIII and transcribed with T7 RNA poly-merase in the presence of [32_{P]CTP to generate a 232-nucleotide probe. Ten} micrograms of total RNA, extracted from unstimulated and phorbol myristate acetate (PMA)-treated primary lymphocytes, was subjected to RNase protection analysis by using this probe and a kit (RPA III; Ambion) according to the manufacturer’s instructions. Protected fragments were separated on a 6% acryl-amide gel, detected by autoradiography, and quantitated by densitometry.

Cell transfection assays.To determine the transcriptional activity ofcycT1

promoter constructs, 293T cells were transfected with 200 ng of a luciferase reporter plasmid and 100 ng of pBC12/CMV/lacZ using Lipofectamine Plus (Life Technologies), and the enzymatic activities were measured 48 h later by using the Luciferase Assay System (Promega) and Galacto-Star (Tropix) kits. Alterna-tively, Jurkat E6 and U937 cells were transfected by electroporation at 280 V and 1,500␮F (Jurkat) and at 300 V and 1,500␮F (U937). In these cases, 5⫻106_cells were transfected with 5␮g of the luciferase reporter plasmids and 2.5␮g of pBC12/CMV/lacZ, and the luciferase and␤-galactosidase activities in cell lysates were measured 24 h after transfection. Primary lymphocytes from healthy donors were isolated by Ficoll gradient centrifugation and resuspended in RPMI sup-plemented with 10% fetal calf serum. For analysis ofcycT1promoter activity, 107 cells were mixed with 10␮g of luciferase reporter plasmids and 5␮g of pBC12/ CMV/lacZ. Alternatively, to measure Tat function in primary lymphocytes, cells were mixed with 10␮g of pHIV/luc, 10␮g of pcTat, and 5␮g of pBC12/CMV/ lacZ. Cells were electroporated at 320 V and 1,500␮F, and the luciferase and ␤-galactosidase activities in cell lysates were measured 24 h later. PMA (Sigma) was added at 25 ng/ml to some cultures 2 h after electroporation.

Western blot analysis.Protein extracts were prepared by lysing cells in a buffer containing 125 mM Tris (pH 6.8), 10% glycerol, 2% sodium dodecyl sulfate, 0.1 M dithiothreitol, and a protease inhibitor cocktail (Roche). Immediately after cell lysis, the samples were boiled for 5 min and 10␮g of protein extract from cell lines or primary lymphocytes was separated in a 7% polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane that was sequentially probed with the C-20 anti-goat polyclonal antibody raised against cyclin T1 (Santa Cruz) diluted 1/500 and with an anti-goat peroxidase antibody (Roche). Thereafter, blots were developed by using chemiluminescent substrate reagents (Pierce). In some experiments, blots were also probed with an anti-ERK-1 monoclonal an-tibody to confirm equivalent loading. In addition, when primary lymphocytes were analyzed, aliquots of cells were subjected to fluorescence-activated cell sorting (FACS) analysis by using an anti-CD69 monoclonal antibody, prior to lysis, to confirm the resting and activated states of the unstimulated and PMA-treated cells, respectively.

RESULTS

Definition of functionalcycT1promoter sequences.To de-fine promoter sequences that are functionally important in the regulated expression of CycT1, 2,051 nucleotides situated 5⬘to

the cycT1 translation start site were amplified from human

genomic DNA. Subsequent functional analysis determined the entire promoter activity resides in the 545 nucleotides 5⬘to the translation initiation site, which hereafter is referred to as position⫹1. The 545 nucleotides that comprise the fullcycT1

promoter are shown in Fig. 1, aligned with the corresponding region of mouse genomic DNA whose sequence became avail-able during the course of these studies. ThecycT1promoter contains a wide array of sequence motifs that could, poten-tially, serve as binding sites for a variety of transcription fac-tors. It is notable that the presence of some putative transcrip-tion factor binding sites are conserved in both species, most

on November 8, 2019 by guest

http://jvi.asm.org/

notably those for Sp1 and the Ets family of transcription fac-tors. In contrast, other putative sites are not conserved, par-ticularly those present at more distal positions to the transla-tion start site. A functransla-tional role for these putative binding sites in regulatingcycT1expression is, at present, speculative and has not been determined by functional assays.

Therefore, to perform a preliminary functional analysis of

thecycT1promoter, a 2,051-nucleotide DNA sequence located

immediately 5⬘ to thecycT1translation initiation site was in-serted into a luciferase reporter vector. Transfection of this construct resulted in readily detectable luciferase expression in a variety of cell lines that was ca. 100-fold greater that that observed upon transfection of the control vector (Fig. 2), in-dicating that this sequence indeed contains a functional pro-moter. Subsequently, a series of 5⬘ and 3⬘ deletion mutants were constructed and tested in three cell lines. Specifically, 293T (fibroblast), Jurkat (CD4⫹T-cell), and U937 (promono-cyte) cell lines were included in this analysis in an attempt to uncover any potential tissue-specific functional elements in the

cycT1 promoter. In addition, the latter two cell lines were

included because they represent functional target cells for HIV-1 infection and respond to extracellular stimuli that might influence promoter activity. The results of these experiments are shown in Fig. 2. This analysis clearly demonstrated that for each cell line the entire promoter activity of the cloned 2,051-nucleotide fragment resides in the 545 2,051-nucleotides 5⬘ to the

cycT1 coding sequence. Specifically, a promoter containing

these 545 nucleotides was at least as active in each cell line as was a promoter containing additional 5⬘sequences up to and including the entire 2,051-nucleotide sequence (data not shown). Conversely, removal of these 545 nucleotides from the 2,051-nucleotide fragment resulted in the complete loss of promoter activity (Fig. 2B). Smaller deletions from the 3⬘end of the 2,051-nucleotide sequence resulted in either partial or no loss in promoter activity in each cell line. These results define the 5⬘boundary of thecycT1promoter as lying between 299 and 545 nucleotides 5⬘to the translation initiation site.

Progressive 5⬘-to-3⬘ deletion analysis of this 545 nucleotide FIG. 1. Conservation and divergence in putative transcription factor binding sites present in the human and murinecycT1promoters. The sequence of the 545-nucleotide humancycT1promoter is shown, aligned with the corresponding murine genomic sequence. Transcription factor binding sites, predicted by using MacVector (Oxford Molecular) or Transcription Element Search Software (TESS), are indicated by boxes. Arrows indicate major discrete sites of transcription initiation, as defined in Fig. 5.

210 MARTIN-SERRANO ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

sequence, shown in Fig. 2A, initially revealed modest effects on promoter activity. Indeed, fragments containing 350, 299, 265, or 205 nucleotides 5⬘ to the cycT1 translation initiation site retained 70 to 100% of the activity of the intact 545-nucleotide promoter. Further, 5⬘-to-3⬘deletions had more significant and cell-type dependent effects on promoter activity. Specifically, removal of sequences between position⫺205 and either posi-tion⫺165 or position⫺120 resulted in fragments that retained 60 to 100% activity in Jurkat cells but only 20 to 30% activity in either 293T or U937 cells. In addition, very small 3⬘ frag-ments of the cycT1 promoter (98 and 76 nucleotides) were inactive in 293T and U937 cells but retained approximately 10% of the activity of the full 545-nucleotide promoter in Jurkat cells.

Conversely, 3⬘-to-5⬘deletion analysis, shown in Fig. 2B, did not reveal any major cell type-dependent differences in the activity of truncated promoters. In all three cell lines, the deletion of 116 nucleotides from the 3⬘end of the promoter sequence did not result in any significant loss in activity. How-ever, further 3⬘deletions of 205 or 299 nucleotides resulted in

similar, partial losses in promoter activity in each cell line. Interestingly, when viewed in combination, these 5⬘ and 3⬘

deletion analyses reveals functional redundancy in thecycT1

promoter; sequences which are in themselves fully sufficient to act as promoters can be deleted without loss of promoter activity. For example, the 116 nucleotides situated at the 3⬘end of the promoter that are not required for full promoter activity in any cell line (Fig. 2B) nevertheless constitute a fully active promoter in Jurkat cells and a partially active promoter in 293T and U937 cells (Fig. 2A).

These results are largely consistent with a recent study of Liu and Rice (34), who concluded that the cycT1 promoter in-cludes two regions with critical regulatory elements, situated between positions ⫺503 and ⫺190 and positions ⫺146 and

⫺92. However, to functionally dissect thecycT1promoter in more detail, we constructed a series of reporter plasmids that combined both 5⬘and 3⬘deletions and analyzed their ability to function as promoters in the three cell lines. Since the results obtained with 293T and U937 cells were very similar, only those obtained with 293T cells are presented, in addition to FIG. 2. Functional analysis of thecycT1promoter in immortalized cell lines. Jurkat (T cells), 293T (epithelial), or U937 (monocytic) cell lines were transfected with pGL3-derived luciferase reporter plasmids. (A) The 5⬘deletion series contains human genomic sequences from the CycT1 translation intiation site extending 5⬘to the indicated nucleotide; 545R represents the complete 545-nucleotide promoter iserted into pGL3 in the reverse orientation. (B) The 3⬘deletion series contains sequences from position⫺2051 relative to the CycT1 translation initiation site extending 3⬘to the indicated nucleotide. In each case, cells were cotransfected with pBC12/CMV/lacZ. The luciferase and␤-galactosidase activities were determined in cell lysates 48 h after transfection. Promoter activity is expressed as a percentage of the luciferase activity present in cells transfected with a reporter plasmid containing the 545-nucleotide promoter (determined, by this analysis, to contain the entire transcription promoting activity) and were normalized for minor variations in transfection efficiency, as determined from the␤-galactosidase activity.

on November 8, 2019 by guest

http://jvi.asm.org/

those obtained using Jurkat cells. These results are summa-rized in Fig. 3 and reveal a remarkable level of functional redundancy in thecycT1promoter. Ultimately, we defined no less than five nonoverlappingcycT1promoter fragments that retained 10 to 20% of the activity of the intact promoter in at least one of the cell lines. For simplicity we have termed these promoter “modules” A (⫺545 to⫺300), B (⫺299 to⫺206), C (⫺205 to⫺117), D (⫺116 to⫺80), and E (⫺79 to⫹1).

As is shown in Fig. 3, combinatorial analysis of these con-tiguous minimal promoter modules revealed a complex rela-tionship between sequence elements that can act either syner-gistically, additively, or redundantly to promote cycT1

transcription. In fact, each combination of two contiguous min-imal promoter elements (A-B, B-C, C-D, and D-E) gave pro-moter activities that were greater the sum of the individual contributing elements. For example, promoter module E was inactive in 293T cells and possessed ca. 10% of the activity of the intactcycT1promoter in Jurkat cells. Similarly, module D

possessed only 2.4% activity in 293T cells and 10% of the intact promoter activity in Jurkat cells (Fig. 3). However, when present in combination, in module D-E, the 108 and 23% of the intact promoter activity was observed in Jurkat and 293T cells, respectively. Clearly, therefore, elements contained within these minimal modules can act synergistically to drive transcription by thecycT1promoter. The one exception to this finding was the C-D combination, which gave 39% of full promoter activity in Jurkat cells, a value approximately equal to the sum of that of the individual C (27%) and D (10%) modules. The addition of a third minimal promoter module to each of the two module combinations had variable effects on promoter activity. For instance, the addition of module A to the B-C combination (resulting in A-B-C) significantly en-hanced the promoter in each cell line. Similarly, A-B-C was significantly more active than A-B. Taken together, these re-sults suggest that elements in modules A, B, and C act coop-eratively to promotecycT1transcription. In contrast, the pres-FIG. 3. Combinatorial analysis of minimally active cycT1 promoter fragments in immortalized cell lines. (A) Minimal cycT1 promoter fragments, found to retain at least 10% of the intact promoter activity are termed modules A (⫺545 to⫺300), B (⫺299 to⫺206), C (⫺205 to ⫺117), D (⫺116 to⫺80), and E (⫺79 to⫹1). These were analyzed individually or as all possible contiguous combinations of two, three, or four modules. (B) Luciferase activities resulting from transfection of Jurkat and 293T cells with reporter plasmids are expressed as a percentage of that obtained after transfection of a construct containing the intact 545-nucleotidecycT1promoter.

212 MARTIN-SERRANO ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

ence of the D module in the context of a promoter containing both B and C elements had no enhancing effect on activity (compare B-C versus B-C-D in Fig. 3). In fact, the contribution of module D to promoter activity was highly context depen-dent: it potently enhanced promoter activity in the context of a D-E combination and, more modestly, in the context of a C-D combination. This observation suggests that sequences in mod-ule D can act cooperatively with those present in E and, to a lesser extent, in C but not in A or B to promotecycT1 tran-scription. This conclusion is supported by the observation that the addition of module E to the C-D combination (resulting in C-D-E) also significantly enhanced promoter activity (Fig. 3). The addition of either module A or module E to the central B-C-D module combination, to give A-B-C-D and B-C-D-E, respectively, also resulted in significant increases in activity so that each four module-containing promoters possessed 75 to 100% of the activity of the intactcycT1promoter (Fig. 3).

Comparison of the activities of these two- and three-module containing, truncated promoters clearly demonstrates a signif-icant degree of functional redundancy in thecycT1promoter. Both the A-B-C and the C-D-E promoter constructs possessed activities that are close to or equal to that of the intact pro-moter in both cell lines. In fact, it proved possible to derive two nonoverlapping portions of thecycT1promoter that retained activities that were at least as high as that of intact promoter in Jurkat cells (A-B-C and D-E; Fig. 3).

Definition ofcycT1promoter elements that respond to cel-lular activation stimuli.Having defined minimal promoter el-ements that contribute to the transcription of thecycT1gene, we next sought to identify which, if any, of these sequences is responsible for the upregulation of cycT1 expression in re-sponse to cellular activation stimuli. Unfortunately, we were unable to identify any cellular activation stimulus that resulted in a robust increase in the activity of thecycT1promoter in either Jurkat or U937 cells. Liu and Rice recently reported that a combination of PMA and ionomycin can modestly increase the activity of thecycT1promoter in Jurkat cells (34). How-ever, this effect is ⬍2-fold and unlikely to be sufficient for unambiguous mapping of the elements responsible for activa-tion-induced upregulation.

Consequently, we used experimental conditions (3) that per-mitted the measurement ofcycT1promoter activity in primary lymphocyte cultures. Results from these experiments are shown in Fig. 4. Transfection of a luciferase reporter construct containing the intact 545-nucleotidecycT1promoter resulted in levels of luciferase expression that were readily detectable and three- to four-fold higher than that observed after trans-fection of the control promoterless reporter construct (Fig. 4A). Subsequently, transfected primary lymphocyte cultures were subjected to a variety of activation stimuli. Of these, only PMA treatment led to a robust and reproducible increase (ca. fourfold) in the level ofcycT1promoter driven luciferase ex-pression (Fig. 4A and data not shown). To confirm that this PMA-mediated effect was not simply an artifact of using trans-fected plasmid DNA, we also measured the level of cycT1

mRNA expression from the endogenouscycT1gene by using untransfected cells. As is shown in Fig. 4B, PMA treatment resulted in a similar increase (three- to fourfold) in the level of endogenouscycT1transcription, as measured by RNase pro-tection assay. The magnitude of these effects was similar to that

observed when the cytomegalovirus (CMV) promoter, which is known to be PMA responsive, was used in place of thecycT1

promoter (Fig. 4C).

Thereafter, we used selected constructs to determine which of the minimalcycT1promoter modules, described in Fig. 3, mediate both basal and PMA-responsive reporter gene expres-sion in primary lymphocyte cultures. As is shown in Fig. 4D, a truncated promoter consisting of modules D and E appeared to be as active as the intactcycT1promoter. This is a similar result to that obtained with the Jurkat T-cell line (Fig. 3). Furthermore, this D-E promoter module combination was clearly PMA responsive, albeit slight less so than the intact

cycT1promoter. Module D was required for PMA-responsive

transcription in this context because no PMA-induced en-hancement of reporter gene expression was observed with a construct that contained module E alone. Surprisingly, a pro-moter containing only modules B and C had a higher basal activity than the intactcycT1promoter, but these modules did not exhibit any increase in reporter gene expression upon PMA treatment of transfected cells. Promoter module A, how-ever, exhibited both a higher basal level of expression and was responsive to PMA treatment. These data suggested that at least one element exists in thecycT1promoter that can inhibit transcription in primary lymphocytes. To address this further, cells were transfected with reporter constructs that contained either A-B, A-B-C, or A-B-C-D module combinations (Fig. 4D). As expected, each of these truncated promoters retained at least some degree of PMA responsiveness. However, a pro-moter containing modules A and B exhibited lower activity in both the presence and the absence of PMA than did one containing module A alone, suggesting that sequences in mod-ule B can exert an inhibitory effect in this context. Likewise, a promoter containing module combination A-B-C-D possessed a lower activity than did one containing A-B-C. Nevertheless, A-B-C-D was slightly more active than the intact promoter, A-B-C-D-E. It appears, therefore, that sequences in modules B, D, and E can exert an inhibitory effect on both basal and PMA-activated transcription driven bycycT1promoter in pri-mary lymphocytes, depending on the context in which they are present.

Overall, the data in Fig. 4D indicates that the cycT1 pro-moter contains at least three sequence elements that are ca-pable of functioning independently and contribute to overall promoter activity in transfected primary lymphocytes: (i) a distal element within module A that contributes to both basal and PMA-responsive transcription, (ii) a central element con-tained within modules B and C that contributes to the basal transcription but not PMA responsiveness, and (iii) a proximal element contained within modules D and E that contributes to both basal and PMA-activated transcription. In addition, it appears that sequences within thecycT1promoter can exert a context-dependent inhibitory influence on promoter activity.

Changes in the utilization of transcription initiation sites within thecycT1promoter upon cellular activation.The find-ing that no sfind-ingle module within thecycT1promoter was re-quired for efficient transcription suggested that more than one sequence was at least capable of serving as a transcription initiation site. To address this specifically, we performed primer extension analyses of endogenous cycT1 mRNA by using a primer complementary to the extreme 5⬘ end of the

on November 8, 2019 by guest

http://jvi.asm.org/

FIG. 4. Analysis ofcycT1promoter activity in primary lymphocytes. (A) Primary lymphocytes obtained from a normal donor were electropo-rated with pGL3-based plasmids either that lacked a promoter or contained the 545-nucleotidecycT1promoter. (B) RNase protection analysis of endogenouscycT1transcription with total RNA extracted from nontransfected, unsimulated (Uns) or PMA-treated primary lymphocytes. Lanes: Pr, undigestedcycT1probe;⫺, digested probe after hybridization with yeast tRNA. (C) Cells from the same donor as in panel A were transfected with pBC12/CMV/lacZ. For both panels A and C, cells were either left unstimulated or were treated with PMA after transfection. Luciferase or ␤-galactosidase activities in cell lysates were determined 24 h after electroporation and are representative of at least three independent experiments. (D) Primary lymphocytes were electroporated with reporter plasmids containing selectedcycT1promoter fragments, and cells either were left unstimulated or were treated with PMA. Results are presented as the fold increase in luciferase activity (⫾the standard deviation) over that obtained with a promoterless reporter plasmid and lymphocytes from three different donors.

214 MARTIN-SERRANO ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

cycT1coding sequence. RNA isolated from several cell lines was analyzed, and these data are presented in Fig. 5A. In all cell lines examined, two discrete major transcription start sites were detected at around positions⫺80 and⫺200. In addition, several minor bands were observed as well as a heterogeneous population of higher-molecular-weight extension products that could not be resolved to determine discrete initiation sites. It was initially unclear whether these minor bands represent spe-cific transcription start sites. Nevertheless, it is clear that the start sites at positions⫺80 and⫺200 are, in part, redundant since high level activity could be observed in truncated pro-moters that lacked one or other of these sites. Indeed, the promoter module combination A-B, which lacks both of these discrete sites, retained 35 and 60% of full promoter activity in 293T and Jurkat cells (Fig. 3), respectively, and full activity in primary lymphocytes (Fig. 4), indicating that neither is essen-tial.

A recent analysis of thecycT1promoter by Liu and Rice (34) indicated the presence of transcription initiation sites at ap-proximately positions⫺80 and⫺135, as determined by RNase protection assays, and at ⫺323 and ⫺324 as determined by primer extension. The data presented here are partially con-cordant with these findings, However, the⫺323 and⫺324 start sites reported by Liu and Rice would fall within the heteroge-neous high-molecular-weight extension products observed in our experiments. In addition, we did not detect a major

tran-scription start site at⫺135 (although minor bands in this re-gion were observed). Instead, we clearly observed transcripts initiating at ⫺200. Despite these minor discrepancies, which could, in part, be due to the different RNA source (HL-60 cells) used by Liu and Rice (34), it is abundantly clear that transcription can initiate at multiple sites within the cycT1

promoter.

To investigate whether endogenous cycT1transcription in general, and start site utilization in particular, could be influ-enced by cellular activation state, we isolated RNA from pri-mary lymphocytes that were either unstimulated or had been treated with various activating agents. Primer extension anal-yses of these RNAs are presented in Fig. 5B. Unstimulated lymphocytes contained a particularly diverse population of

cycT1 transcripts, initiated at multiple sites, with the most

prominent start site positioned at ⫺80. A minor degree of donor-to-donor variation in the pattern of primer extension products obtained with unstimulated primary lymphocytes was evident (compare Fig. 5B and C). Upon stimulation with PMA, however, a dramatic change in the utilization of transcription start sites was observed (Fig. 5B). Specifically, PMA reproduc-ibly increased the utilization of discrete transcription start sites at positions ⫺40, ⫺80, and ⫺200. In addition, an increased level of the heterogeneous high-molecular-weight primer ex-tension products was clearly observed upon analysis of RNA from PMA-treated cells. Thus, PMA-inducedcycT1transcripts FIG. 5. Transcription start site utilization at thecycT1promoter in immortalized cell lines and primary lymphocytes. (A) Total RNA was obtained from a panel of immortalized cell lines and subjected to primer extension analysis with an oligonucleotide proximal to thecycT1

translation start site (T1GP1; see Materials and Methods). Similar analyses were done with RNA extracted from primary lymphocytes that were either unstimulated or subjected to treatment with PMA for 24 h (B) or treatment with either PHA or␣CD3 antibody for 24 and 48 h (C). The bar in panel B indicates the boundaries of the promoter modules A, B, C, and D as defined in Fig. 3.

on November 8, 2019 by guest

http://jvi.asm.org/

appear to initiate predominantly within promoter modules A and D-E. This result correlates with the ability of these pro-moter modules to mediate enhanced reporter gene expression in response to the PMA treatment of transfected primary lym-phocytes (Fig. 4).

Slightly different results in the pattern ofcycT1specific tran-script initiation were obtained with primary lymphocytes that had been treated with either phytohemagglutinin (PHA) or with an ␣CD3 antibody (Fig. 5C). In this case, stimulation appeared to markedly reduce the complexity of the pattern of primer extension products. Specifically, many of the minor primer extension products that were observed with RNA iso-lated from unstimuiso-lated cells were not detected when PHA- or anti-CD3-stimulated cells were analyzed. Instead, transcription start sites at ⫺80 and ⫺200 were utilized somewhat more efficiently, and there was a dramatic increase in the level of heterogeneous high-molecular-weight extension products. These effects were more evident at 48 h after treatment than after 24 h. The transcription initiation site at around position

⫺40, which was induced by PMA, was not induced by either PHA or␣CD3. In contrast to unstimulated primary lympho-cytes, the pattern of transcription initiation sites observed in PHA- or anti-CD3-treated cells closely resembled that ob-served in the panel of immortalized cell lines shown in Fig. 5A. In summary, these analyses demonstrate that cellular activa-tion dramatically influences transcripactiva-tion start site selecactiva-tion but results in a modest overall increase incycT1transcription (Fig. 4B).

CycT1 is expressed at sufficient levels to support efficient Tat function in unstimulated primary lymphocytes.Previously, it has been reported that CycT1 protein levels are low in unstimulated lymphocytes (25, 26), and this led to the hypoth-esis that activation-induced replication of HIV-1 in primary lymphocyte cultures is a consequence of increased levels of CycT1 expression (44, 48). Indeed, the reported excess of short compared to long HIV-1 transcripts in the unstimulated lym-phocytes of HIV-1-infected individuals (1) would be the pre-dicted consequence of defective Tat function consequent to limiting levels of CycT1. However, we observed rather modest upregulation ofcycT1promoter-driven reporter gene expres-sion and concordant increases in the total level of cycT1

mRNA (Fig. 4) in response to a potent activation stimulus (PMA). These observations prompted us to reexamine the level of CycT1 protein in stimulated versus unstimulated pri-mary cells and to ask whether this level is sufficient to support Tat function. Therefore, we obtained primary lymphocytes from multiple HIV-negative donors and examined the level of CycT1 protein expression by Western blotting. CycT1 expres-sion in the untreated and PMA-stimulated lymphocytes of three representative donors is shown in Fig. 6A. In fact, we observed only small increases in CycT1 protein levels in re-sponse to PMA in all donors examined. In some cases, we also performed Western analysis with a monoclonal antibody spe-cific for ERK-1, whose expression remains constant upon ac-tivation, to confirm equivalent gel loading. Moreover, analysis of activation marker (CD69) expression in primary lympho-cytes established the resting and activated states of the un-stimulated and PMA-treated cells, respectively (Fig. 6A). This modest increase in CycT1 protein levels upon PMA treatment can readily be accounted for (and, in fact, appears to be less

than) the increase in transcription from thecycT1promoter in response to PMA activation (Fig. 4 and 5). Similar results were obtained when PHA was used as the stimulus and are in con-trast with the previously reported marked increase in CycT1 protein levels in primary lymphocytes after PMA or PHA ac-tivation (25, 26).

We further examined, in a comparative manner, the level of CycT1 protein present in unstimulated primary lymphocytes and a panel of immortalized cell lines in which HIV-1 has been shown to replicate efficiently or have been documented to support robust Tat activity. A representative experiment is shown in Fig. 6B. In fact, CycT1 expression in unstimulated primary lymphocytes was only slightly lower than that observed in each of the immortalized cell lines. This observation argues against the notion that a lack of CycT1 expression limits Tat function and HIV-1 gene expression in unstimulated primary lymphocytes.

However, to address this question directly, we performed transfection experiments in which an HIV-1 LTR promoter-driven luciferase reporter plasmid was electroporated into primary lymphocytes in the presence or absence of a Tat ex-pression plasmid. These results are shown in Fig. 6C. After transfection, cells were cultured for 24 h in the absence of stimulation or were treated with PMA. While PMA clearly induces the HIV-1 LTR (and the cotransfected CMV-LacZ control plasmid) approximately fourfold, it is clear that PMA treatment had only minor effects on Tat function. Indeed, Tat was able to transactivate the HIV-1 LTR 40- to 45-fold in primary cells that were otherwise unstimulated, a result that is similar to that observed in many immortalized cell lines. PMA treatment did result in a small but measurable increase (two-to threefold) in Tat transactivation. However, this is as likely due to a PMA-induced increase in Tat expression (mediated by the CMV promoter in pcTat) or to synergy between PMA-induced transcription initiation and Tat-PMA-induced transcription elongation, as to the minor increase in CycT1 expression ob-served upon PMA treatment of primary lymphocytes. Clearly, CycT1 and P-TEFb levels do not appear to profoundly limit Tat function in unstimulated primary lymphocytes.

DISCUSSION

In this report, we have determined that the cycT1 gene harbors a complex promoter containing elements that can function both cooperatively and redundantly to mediate tran-scription. Initiation ofcycT1transcription can occur at multi-ple sites within the promoter (Fig. 5) (34), a feature that is not unusual among the constitutively active Tata-less promoters that are typical of “housekeeping” genes. Other features of the

cycT1 promoter that are often shared among housekeeping

genes include the fact that it is situated within a CpG-rich “island” and contains significant functional redundancy (4, 46). However, it is remarkable and without precedent (as far as we are aware) that no less than five nonoverlapping fragments of the complete promoter exhibit an ability to promote transcrip-tion to a significant degree (Fig. 3). It is also noteworthy that no single sequence element within thecycT1promoter, includ-ing a consensus TATA element located at position⫺378, ap-pears to be essential for full activity. This finding makes an assessment of a role for individual transcription factors in

216 MARTIN-SERRANO ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

drivingcycT1transcription problematic; while there are many predicted binding sites for transcription factors in thecycT1

promoter (Fig. 1) (34), none appears to be essential forcycT1

transcription. Moreover, it appears that, with the exception of four binding sites for Ets family transcription factors, none of

the putative transcription factor binding sites are conserved in the human and murine cycT1 promoters. It appears likely, therefore, that evolution has selected cycT1 promoter se-quences that are active in a wide variety of cell types, in dif-ferent states of activation, in which difdif-ferent transcription fac-FIG. 6. CycT1 is expressed in unstimulated primary lymphocytes at levels sufficient to support Tat function. (A) Western blot analysis of CycT1 expression in primary lymphocytes obtained from three representative donors that either were unstimulated or were treated with PMA for 24 h. As a loading control, some blots were also probed with an anti-ERK-1 antibody. The panel to the right shows FACS analysis of unstimulated and PMA-treated lymphocytes with an anti-CD69 monoclonal antibody. (B) Comparative Western blot analysis of CycT1 expression levels in freshly isolated, unstimulated primary lymphocytes and a panel of immortalized cell lines known to support HIV-1 Tat function or virus replication. (C) Analysis of Tat function in unstimulated or PMA-treated primary lymphocytes. Data obtained with lymphocytes from two representative donors, electroporated with pHIV/luc, pBC12/CMV/lacZ, and either pcTat or pBC12/CMV is shown. The luciferase and␤-galactosidase activities in cell lysates were determined 24 h after electroporation. For each experiment, the fold increase in luciferase expression in response to Tat is shown.

on November 8, 2019 by guest

http://jvi.asm.org/

tors might be present, without a specific requirement for a given promoter sequence or transcription factor.

Nevertheless, the conservation of the putative Ets binding sites in human and murinecycT1promoters is striking (Fig. 1). The Ets family of transcriptional regulators is large and diverse and binds to the core sequence GGAA/T with proximal se-quences (up to a total of 15 nucleotides) influencing which particular Ets family member is recruited (reviewed in refer-ence 45). The Ets core binding site occurs five times in between positions⫺180 and ⫺40 in the 3⬘ portion of thecycT1 pro-moter (Fig. 1). Each of these elements is homologous to se-quences previously shown to act as binding sites for either the Ets-1, PEA3, Ets-2, or PU.1 members of the Ets family. Inter-estingly, Ets-1 and -2 are known to be reciprocally regulated during T-cell activation; in resting cells Ets-2 is abundant and Ets-1 is poorly expressed, whereas the converse is the case in activated T cells (6). It is likely, therefore, thatcycT1promoter modulation and transcription start site selection within the 3⬘

portion of the promoter could be mediated, in part, by Ets family factors. Indeed, initiation site selection in primary lym-phocyte cells appeared to be highly dependent on the cellular activation state (Fig. 5). These findings are consistent with the notion that the position to which the RNAPII complex is recruited and initiates transcription within a Tata-less pro-moter is, in part, dependent on the array of transcription fac-tors bound to the regulatory sequences within promoter ele-ments. Clearly, the analysis of deleted cycT1 promoter constructs reveals that CycT1 expression is not entirely depen-dent on Ets family members nor on any other single transcrip-tion factor.

Despite the quite dramatic changes in cycT1transcription start site selection that occur upon cellular activation (Fig. 5), unstimulated primary lymphocytes retain significantcycT1 pro-moter activity and contain readily detectable levels of CycT1 protein (Fig. 4, 5, and 6). In these experiments, very little change in the steady-state levels of CycT1 protein in either cell lines or primary lymphocytes were detected in response to exogenous activation stimuli. This finding contrasts with those of Garriga et al. and Hermann et al. (25, 26) and may relate to the different methods used for cell lysis. In some cell lines, notably U937, we found it difficult to detect CycT1 protein by Western blotting when cells were disrupted by nondenaturing lysis buffers (data not shown). In contrast, cell lysis under denaturing conditions prior to Western blotting led to a rather uniform yield of CycT1 protein (Fig. 6). In fact, it has been recently shown that a proportion of CycT1 is associated with the insoluble nuclear matrix and is not efficiently extracted by using nondenaturing detergents (27). The discrepancies be-tween this and previous studies may, therefore, be a conse-quence of cell type- or activation state-dependent differences in the localization and/or biochemical properties of CycT1 protein.

It is somewhat surprising that both cycT1promoter-driven reporter gene expression (Fig. 4) and endogenous cycT1

mRNA levels (Fig. 5) are measurably increased by activation of primary lymphocytes, and yet changes in the CycT1 protein levels are barely detectable (Fig. 6). CycT1 appears to be relatively stable in 293T cells, with a half-life of ca. 48 h (42), despite the presence of a putative PEST sequence. Whether this is true in all cellular contexts is unclear. It might be that

cellular activation increases both synthesis and degradation of CycT1. Nevertheless, the steady-state levels of CycT1 do not appear to dramatically change in response to cellular activa-tion.

An important functional consequence of these findings is that the HIV-1 Tat protein, which activates transcription by recruitment of the CycT1 containing form of P-TEFb to the viral LTR promoter, possesses significant intrinsic activity in unstimulated primary lymphocytes. In fact, PMA activation leads to an only two- to three-fold increase in Tat activity (Fig. 6). Other variables, such as NF-␬B activity, which is dramati-cally influenced by the cellular activation state, and the site of proviral integration have been clearly demonstrated modulate the level of gene expression from the HIV-1 LTR (3, 13, 30, 39, 40, 54). Given these observations and the findings reported here, it appears extremely unlikely that the transcriptional ac-tivity or latency of the HIV-1 provirus in vivo is explained by the presence of limiting quantities of the CycT1 containing form of P-TEFb.

ACKNOWLEDGMENTS

We thank Amanda Brown, Cecilia Cheng-Mayer, and Mark Muesing for gifts of reagents.

This work was supported by the Donald A. Pels Charitable Trust.

REFERENCES

1.Adams, M., L. Sharmeen, J. Kimpton, J. M. Romeo, J. V. Garcia, B. M. Peterlin, M. Groudine, and M. Emerman.1994. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA91:3862–3866.

2.Albrecht, T. R., L. H. Lund, and M. A. Garcia-Blanco.2000. Canine cyclin T1 rescues equine infectious anemia virus tat trans-activation in human cells. Virology268:7–11.

3.Alcami, J., T. Lain de Lera, L. Folgueira, M. A. Pedraza, J. M. Jacque, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, et al.1995. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lympho-cytes. EMBO J.14:1552–1560.

4.Antequera, F., and A. Bird.1999. CpG islands as genomic footprints of promoters that are associated with replication origins. Curr. Biol.9:R661– R667.

5.Barboric, M., R. Taube, N. Nekrep, K. Fujinaga, and B. M. Peterlin.2000. Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus. J. Virol. 74:6039–6044.

6.Bhat, N. K., C. B. Thompson, T. Lindsten, C. H. June, S. Fujiwara, S. Koizumi, R. J. Fisher, and T. S. Papas.1990. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Proc. Natl. Acad. Sci. USA87:3723–3727. 7.Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen.1999. Analysis

of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes. J. Virol. 73:5777–5786.

8.Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen.1999. Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol. Cell. Biol.19:4592–4599.

9.Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen.1998. Recruit-ment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J.17:7056–7065.

10.Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen.1999. Recruit-ment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. USA96:7791–7796.

11.Bogerd, H. P., H. L. Wiegand, P. D. Bieniasz, and B. R. Cullen.2000. Functional differences between human and bovine immunodeficiency virus Tat transcription factors. J. Virol.74:4666–4671.

12.Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson.1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science254:423–427.

13.Chen, B. K., M. B. Feinberg, and D. Baltimore.1997. The␬B sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol.71:5495– 5504.

218 MARTIN-SERRANO ET AL. J. VIROL.

on November 8, 2019 by guest

http://jvi.asm.org/

14.Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci.1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA94:13193–13197.

15.Dahmus, M. E.1996. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem.271:19009–19012.

16.Feinberg, M. B., D. Baltimore, and A. D. Frankel.1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA88:4045–4049. 17.Feng, S., and E. C. Holland.1988. HIV-1 tat trans-activation requires the

loop sequence within tar. Nature334:165–167.

18.Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gal-lant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano.1997. Identification of a reservoir for HIV-1 in patients on highly active antiret-roviral therapy. Science278:1295–1300.

19.Fong, Y. W., and Q. Zhou.2000. Relief of two built-In autoinhibitory mech-anisms in P-TEFb is required for assembly of a multicomponent transcrip-tion elongatranscrip-tion complex at the human immunodeficiency virus type 1 pro-moter. Mol. Cell. Biol.20:5897–5907.

20.Fu, T. J., J. Peng, G. Lee, D. H. Price, and O. Flores.1999. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II tran-scription. J. Biol. Chem.274:34527–34530.

21.Fujinaga, K., T. P. Cujec, J. Peng, J. Garriga, D. H. Price, X. Grana, and B. M. Peterlin.1998. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol.72:7154–7159. 22.Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin.1999.

Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA96:1285–1290.

23.Garber, M. E., T. P. Mayall, E. M. Suess, J. Meisenhelder, N. E. Thompson, and K. A. Jones.2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol.20:6958–6969.

24.Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones.1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev.12:3512– 3527.

25.Garriga, J., J. Peng, M. Parreno, D. H. Price, E. E. Henderson, and X. Grana.1998. Upregulation of cyclin T1/CDK9 complexes during T cell activation. Oncogene17:3093–3102.

26.Herrmann, C. H., R. G. Carroll, P. Wei, K. A. Jones, and A. P. Rice.1998. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J. Virol.72:9881– 9888.

27.Herrmann, C. H., and M. A. Mancini.2001. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J. Cell Sci.114:1491–1503.

28.Herrmann, C. H., and A. P. Rice.1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: can-didate for a Tat cofactor. J. Virol.69:1612–1620.

29.Horvat, R. T., and C. Wood.1989. HIV promoter activity in primary antigen-specific human T lymphocytes. J. Immunol.143:2745–2751.

30.Jordan, A., P. Defechereux, and E. Verdin.2001. The site of HIV-1 integra-tion in the human genome determines basal transcripintegra-tional activity and response to Tat transactivation. EMBO J.20:1726–1738.

31.Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin.1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature330:489–493.

32.Kinoshita, S., L. Su, M. Amano, L. A. Timmerman, H. Kaneshima, and G. P. Nolan.1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity6:235–244.

33.Laspia, M. F., A. P. Rice, and M. B. Mathews.1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell59:283–292. 34.Liu, H., and A. P. Rice.2000. Isolation and characterization of the human

cyclin T1 promoter. Gene252:39–49.

35.Lu, Y. C., N. Touzjian, M. Stenzel, T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1991. The NF-kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation. J. Acquir. Immune. Defic. Syndr. 4:173–177.

36.Majello, B., G. Napolitano, A. Giordano, and L. Lania.1999. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo. Oncogene18:4598–4605.

37.Marciniak, R. A., and P. A. Sharp.1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J.10:4189– 4196.

38.Marshall, N. F., J. Peng, Z. Xie, and D. H. Price.1996. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem.271:27176–27183.

39.Nabel, G., and D. Baltimore.1987. An inducible transcription factor acti-vates expression of human immunodeficiency virus in T cells. Nature326: 711–713.

40.Nahreini, P., and M. B. Mathews.1997. Transduction of the human immu-nodeficiency virus type 1 promoter into human chromosomal DNA by ad-eno-associated virus: effects on promoter activity. Virology234:42–50. 41.Napolitano, G., P. Licciardo, P. Gallo, B. Majello, A. Giordano, and L.

Lania.1999. The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS13:1453–1459.

42.O’Keeffe, B., Y. Fong, D. Chen, S. Zhou, and Q. Zhou.2000. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J. Biol. Chem.275:279–287.

43.Peng, J., Y. Zhu, J. T. Milton, and D. H. Price.1998. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev.12:755–762. 44.Price, D. H.2000. P-TEFb, a cyclin-dependent kinase controlling elongation

by RNA polymerase II. Mol. Cell. Biol.20:2629–2634.

45.Sementchenko, V. I., and D. K. Watson.2000. Ets target genes: past, present and future. Oncogene19:6533–6548.

46.Somma, M. P., C. Pisano, and P. Lavia.1991. The housekeeping promoter from the mouse CpG island HTF9 contains multiple protein-binding ele-ments that are functionally redundant. Nucleic Acids Res.19:2817–2824. 47.Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica.1990.

HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J.9:1551–1560.

48.Taube, R., K. Fujinaga, J. Wimmer, M. Barboric, and B. M. Peterlin.1999. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology264:245–253.

49.Tiley, L. S., S. J. Madore, M. H. Malim, and B. R. Cullen.1992. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev.6:2077–2087.

50.Wada, T., G. Orphanides, J. Hasegawa, D. K. Kim, D. Shima, Y. Yamaguchi, A. Fukuda, K. Hisatake, S. Oh, D. Reinberg, and H. Handa.2000. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH. Mol. Cell 5:1067–1072.

51.Wada, T., T. Takagi, Y. Yamaguchi, D. Watanabe, and H. Handa.1998. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA poly-merase II-dependent transcription in vitro. EMBO J.17:7395–7403. 52.Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones.1998. A

novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell92:451– 462.

53.Wimmer, J., K. Fujinaga, R. Taube, T. P. Cujec, Y. Zhu, J. Peng, D. H. Price, and B. M. Peterlin.1999. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Virology255:182–189.

54.Winslow, B. J., R. J. Pomerantz, O. Bagasra, and D. Trono.1993. HIV-1 latency due to the site of proviral integration. Virology196:849–854. 55.Yamaguchi, Y., T. Takagi, T. Wada, K. Yano, A. Furuya, S. Sugimoto, J.

Hasegawa, and H. Handa.1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97:41–51.

56.Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell61:213–222.

on November 8, 2019 by guest

http://jvi.asm.org/